Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11667692 T cell receptors recognizing HLA-CW8 restricted mutated KRAS

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

June 6, 2023

0

Patent Application Number

167393100

Date Filed

January 10, 2020

0

Patent Citations

US Patent 8383099 Adoptive cell therapy with young T cells

0

US Patent 10117918 Antigen-specific T cell receptors and T cell epitopes

0

Patent Primary Examiner

Zachary S Skelding

0

Disclosed is an isolated or purified T cell receptor (TCR) having antigenic specificity for mutated Kirsten rat sarcoma viral oncogene homolog (KRAS) presented in the context of an HLA-Cw*0802 molecule. Related polypeptides and proteins, as well as related nucleic acids, recombinant expression vectors, host cells, populations of cells, and pharmaceutical compositions are also provided. Also disclosed are methods of detecting the presence of cancer in a mammal and methods of treating or preventing cancer in a mammal.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11667692 T cell receptors recognizing HLA-CW8 restricted mutated KRAS

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.